Clinical Trials
2 trialsNCT06991790 2025-05-28
Sacituzumab Govitecan + Toripalimab as First - Line Therapy for Advanced Triple - Negative Breast Cancer and Biomarker Exploration
Peking University Cancer Hospital & Institute
Recruiting
NCT04234620 2020-01-21
Intensive Medicines Monitoring Study of Toripalimab Monoclonal Injection (Tuoyi) .
Shanghai Junshi Bioscience Co., Ltd.
Unknown